Lucy V Norling
Overview
Explore the profile of Lucy V Norling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
2181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas B, Montero-Melendez T, Oggero S, Kaneva M, Chambers D, Pinto A, et al.
Arthritis Rheumatol
. 2024 Jul;
76(12):1705-1718.
PMID: 39041647
Objective: This study was undertaken to establish the potential therapeutic profile of neutrophil-derived extracellular vesicles (EVs) in experimental inflammatory arthritis and associate pharmacological activity with specific EV components, focusing on...
2.
Hussain M, Austin-Williams S, Wright T, Dhawan U, Pinto A, Cooper D, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38731975
Osteoarthritis (OA) is the most prevalent age-related degenerative disorder, which severely reduces the quality of life of those affected. Whilst management strategies exist, no cures are currently available. Virtually all...
3.
4.
Chen J, Austin-Williams S, ORiordan C, Claria-Ribas P, Sugimoto M, Norling L, et al.
J Innate Immun
. 2023 Apr;
15(1):548-561.
PMID: 37068475
Using a global formyl peptide receptor (Fpr) 2 knockout mouse colony, we have reported the modulatory properties of this pro-resolving receptor in polymicrobial sepsis. Herein, we have used a humanized...
5.
Norling L, Headland S, Dalli J, Arnardottir H, Haworth O, Jones H, et al.
JCI Insight
. 2023 Feb;
8(3).
PMID: 36752208
No abstract available.
6.
Norling L, Halade G
Curr Opin Pharmacol
. 2022 Nov;
67:102317.
PMID: 36368209
No abstract available.
7.
Qin C, Norling L, Vecchio E, Brennan E, May L, Wootten D, et al.
Br J Pharmacol
. 2022 Jul;
179(19):4617-4639.
PMID: 35797341
We discuss the fascinating pharmacology of formylpeptide receptor 2 (FPR2; often referred to as FPR2/ALX since it binds lipoxin A ). Initially identified as a low-affinity 'relative' of FPR1, FPR2...
8.
Oggero S, Godec T, van Gorp R, Pinto A, Schurgers L, Reutelingsperger C, et al.
J Hypertens
. 2022 Jun;
40(8):1522-1529.
PMID: 35730409
Background: Rapid and accurate new biomarkers to predict risk of cardiovascular disease (CVD) are essential. The utility of extracellular vesicles in predicting the CVD risk is postulated, yet it remains...
9.
Iqbal A, Krautter F, Blacksell I, Wright R, Austin-Williams S, Voisin M, et al.
FASEB J
. 2021 Nov;
36(1):e22065.
PMID: 34847625
Neutrophil trafficking is a key component of the inflammatory response. Here, we have investigated the role of the immunomodulatory lectin Galectin-9 (Gal-9) on neutrophil recruitment. Our data indicate that Gal-9...
10.
Chen J, Norling L, Garrido Mesa J, de Paula Silva M, Burton S, Reutelingsperger C, et al.
Proc Natl Acad Sci U S A
. 2021 Sep;
118(38).
PMID: 34526398
Rheumatoid arthritis (RA) carries a twofold increased incidence of heart failure with preserved ejection fraction, accompanied by diastolic dysfunction, which can lead to death. The causes of diastolic dysfunction are...